Evidence map›Paper›PMID 33928147›Full record

ReviewBioMed research international2021

The Use of Radial Artery for CABG: An Update.

Francesco Nappi, Francesca Bellomo, Pierluigi Nappi, Camilla Chello, Adelaide Iervolino, Massimo Chello, Christophe Acar

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06014047 (Graft Patency Between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Study), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06014047 nanot yet recruitingnot on this mapstarted 2023, after this paper: background citation

Graft Patency Between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Study (GRAFT-CAB Study)

TypeinterventionalSponsorChina National Center for Cardiovascular DiseasesRan2023 to 2030Enrolled774ConditionsCoronary Artery DiseaseArmsNo-touch vein graft, Radial artery graft
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Francesco NappiDepartment of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France.ORCID https://orcid.org/0000-0002-9705-5360
Francesca BellomoDepartment of Clinical and Experimental Medicine, University of Messina, Italy.
Pierluigi NappiDepartment of Clinical and Experimental Medicine, University of Messina, Italy.
Camilla ChelloRegenerative Medicine, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID https://orcid.org/0000-0002-3142-1831
Adelaide IervolinoDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCSS, Italy.
Massimo ChelloCardiovascular Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID https://orcid.org/0000-0001-8178-7068
Christophe AcarDepartment of Cardiac Surgery, La Pitié Salpetriere Hospital, Paris, France.
Università Campus Bio-Medico · ITUniversity of Messina · ITAgostino Gemelli University Polyclinic · ITCentre Cardiologique du Nord · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used the radial artery as a second target conduit for coronary artery bypass grafting since 1971. However, randomized clinical studies have demonstrated differences in clinical outcomes between the radial artery and other grafts because these trials are underpowered. As we proceed toward 50 years of experience with radial artery grafting, we examined the literature to define the best second-best target vessel for coronary artery bypass grafting. The literature was reviewed with emphasis, and a large number of randomized controlled trials, propensity-matched observational series, and meta-analyses were identified with a large patient population who received arterial conduit and saphenous vein grafts. The radial artery has been shown to be effective and safe when used as a second target conduit for coronary artery bypass grafting. Results and patency rates were superior to those for saphenous vein grafting. It has also been shown that the radial artery is a safe and effective graft as a third conduit into the territory of the artery right coronary artery. However, there is little evidence based on a few comparable series limiting the use of the gastroepiploic artery. In its fifth decade of use, we can finally deduced that the aorto-to-coronary radial bypass graft is the conduit of choice for coronary operations after the left internal thoracic artery to the left anterior descending artery.

Indexed as

Coronary Artery BypassCoronary AngiographyHumansRadial ArteryTomography, X-Ray ComputedTreatment FailureVascular Patency

Identifiers

PMID33928147
PMCPMC8049807
OpenAlexW3148111404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.